Cell-Cycle Position of Single MYC-Driven Cancer Cells Dictates Their Susceptibility to a Chemotherapeutic Drug
Tatsiana Ryl(Essen University Hospital), Thomas Höfer(Heidelberg University), Andrés F. Flórez(Harvard University), Frank Westermann(German Cancer Research Center), M Friedrich(German Cancer Research Center), Gregor Mönke(German Cancer Research Center), Emma Bell(Ontario Institute for Cancer Research), Sina Gogolin(German Cancer Research Center), Erika E Kuchen(German Cancer Research Center), Chunxuan Shao(German Cancer Research Center), Florian Lamprecht(German Cancer Research Center)
Cited by 81
Related Papers
Analysis of Gene Regulatory Networks in the Mammalian Circadian Rhythm
|PLoS Computational Biology|2008|304
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
|Genome biology|2008|271
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
|Nature Cancer|2022|224
MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival
|Cell Death and Differentiation|2011|153